Isan Chen
Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer
Sonpavde G, Smith M, Lechuga M, Chow-Maneval E, Chen I, Paolini J, Wang S, Templeton A, Vardy J, Clarke S, Armstrong A, Pond G, Michaelson M. Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer. Clin Genitourin Cancer 2014; 12:317-24.
Mar 15, 2014Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer
Mar 15, 2014Clin Genitourin Cancer 2014; 12:317-24
Sonpavde Guru, Smith Matthew R, Lechuga Mariajose, Chow-Maneval Edna, Chen Isan, Paolini Jolanda, Wang Shaw-Ling, Templeton Arnoud, Vardy Janette L, Clarke Stephen J, Armstrong Andrew J, Pond Gregory R, Michaelson M Dror
Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma
Escudier B, Chen I, Maneval E, Flodgren P, Peschel C, Fountzilas G, Mulder S, Srinivas S, Harmenberg U, Gillessen Sommer S, Roigas J, Vogelzang N. Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:4068-75.
Sep 1, 2009Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma
Sep 1, 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:4068-75
Escudier Bernard, Chen Isan, Maneval Edna Chow, Flodgren Per, Peschel Christian, Fountzilas George, Mulder Sasja F, Srinivas Sandhya, Harmenberg Ulrika, Gillessen Sommer Silke, Roigas Jan, Vogelzang Nicholas J